Cargando…
Recurrent Graves’ disease post SARS-CoV-2 infection
A 22-year-old woman was diagnosed with thyrotoxicosis 8 weeks after the diagnosis of a mild COVID-19 infection. She had reported significant unexplained weight loss after testing positive for COVID-19, but failed to seek medical attention. She recovered well from COVID-19, but presented to the emerg...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351485/ https://www.ncbi.nlm.nih.gov/pubmed/34362755 http://dx.doi.org/10.1136/bcr-2021-244714 |
_version_ | 1783735983440658432 |
---|---|
author | Montebello, Annalisa |
author_facet | Montebello, Annalisa |
author_sort | Montebello, Annalisa |
collection | PubMed |
description | A 22-year-old woman was diagnosed with thyrotoxicosis 8 weeks after the diagnosis of a mild COVID-19 infection. She had reported significant unexplained weight loss after testing positive for COVID-19, but failed to seek medical attention. She recovered well from COVID-19, but presented to the emergency department with worsening symptoms of thyrotoxicosis after 2 months. In view of her known history of previously treated Graves’ disease, a recurrence of Graves’ thyrotoxicosis was suspected. A positive thyroid stimulating hormone receptor antibody confirmed the diagnosis. She was started on carbimazole and propranolol treatment with significant improvement of her symptoms. |
format | Online Article Text |
id | pubmed-8351485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-83514852021-08-20 Recurrent Graves’ disease post SARS-CoV-2 infection Montebello, Annalisa BMJ Case Rep Case Report A 22-year-old woman was diagnosed with thyrotoxicosis 8 weeks after the diagnosis of a mild COVID-19 infection. She had reported significant unexplained weight loss after testing positive for COVID-19, but failed to seek medical attention. She recovered well from COVID-19, but presented to the emergency department with worsening symptoms of thyrotoxicosis after 2 months. In view of her known history of previously treated Graves’ disease, a recurrence of Graves’ thyrotoxicosis was suspected. A positive thyroid stimulating hormone receptor antibody confirmed the diagnosis. She was started on carbimazole and propranolol treatment with significant improvement of her symptoms. BMJ Publishing Group 2021-08-06 /pmc/articles/PMC8351485/ /pubmed/34362755 http://dx.doi.org/10.1136/bcr-2021-244714 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://bmj.com/coronavirus/usageThis article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. |
spellingShingle | Case Report Montebello, Annalisa Recurrent Graves’ disease post SARS-CoV-2 infection |
title | Recurrent Graves’ disease post SARS-CoV-2 infection |
title_full | Recurrent Graves’ disease post SARS-CoV-2 infection |
title_fullStr | Recurrent Graves’ disease post SARS-CoV-2 infection |
title_full_unstemmed | Recurrent Graves’ disease post SARS-CoV-2 infection |
title_short | Recurrent Graves’ disease post SARS-CoV-2 infection |
title_sort | recurrent graves’ disease post sars-cov-2 infection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351485/ https://www.ncbi.nlm.nih.gov/pubmed/34362755 http://dx.doi.org/10.1136/bcr-2021-244714 |
work_keys_str_mv | AT montebelloannalisa recurrentgravesdiseasepostsarscov2infection |